MetaADEDB 2.0 @ LMMD
Ivabradine
(ACRHBAYQBXXRTO-OAQYLSRUSA-N)
Structure
SMILES
COc1cc2C[C@@H](c2cc1OC)CN(CCCN1CCc2c(CC1=O)cc(c(c2)OC)OC)C
Type(s)
Approved
ATC code(s)
C01EB17; C07FX05; C07FX06
Molecular Formula:
C27H36N2O5
Molecular Weight:
468.585
Log P:
3.2479
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
0
TPSA:
60.47
CAS Number(s):
155974-00-8
Synonym(s)
1.
Ivabradine
2.
7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one
3.
Corlanor
4.
S 16257
5.
S 16257-2
6.
S 16260-2
7.
S-16257
8.
S-16257-2
9.
S-16260-2
10.
S 16257 2
11.
S 162572
12.
S 16260 2
13.
S 162602
14.
S16257
15.
S162572
16.
S162602
External Link(s)
MeSHD000077550
PubChem Compound132999
BindingDB50326992
ChEBI85966
CHEMBLCHEMBL471737
DrugBankDB09083
DrugCentral3312
IUPHAR/BPS Guide to PHARMACOLOGY2357
KEGGdr:D07165
Therapeutic Target DatabaseD0S9QA
ZINC3805768
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 46SIDER
US FAERS
2Visual ImpairmentFAERS: 30SIDER
US FAERS
3Atrial FibrillationFAERS: 27SIDER
US FAERS
4FatigueFAERS: 27SIDER
US FAERS
5BradycardiaFAERS: 26SIDER
US FAERS
6NauseaFAERS: 25SIDER
US FAERS
7Feeling abnormalFAERS: 23SIDER
US FAERS
8Drug dose omissionFAERS: 21US FAERS
9HypotensionFAERS: 18SIDER
US FAERS
10MalaiseFAERS: 18SIDER
US FAERS
11PalpitationsFAERS: 18SIDER
US FAERS
12HeadacheFAERS: 17SIDER
US FAERS
13Chest PainFAERS: 14US FAERS
14Drug ineffectiveFAERS: 12US FAERS
15TachycardiaFAERS: 12US FAERS
16AstheniaFAERS: 11SIDER
US FAERS
17Unevaluable eventFAERS: 11US FAERS
18Intentional product misuseFAERS: 9US FAERS
19PhotophobiaFAERS: 9US FAERS
20SyncopeFAERS: 9SIDER
US FAERS
21Therapeutic response unexpectedFAERS: 8US FAERS
22UrticariaFAERS: 8SIDER
US FAERS
23Adverse eventFAERS: 7US FAERS
24PruritusFAERS: 7SIDER
US FAERS
25Sinus TachycardiaFAERS: 7US FAERS
26VomitingFAERS: 7US FAERS
27Wrong technique in product usage processFAERS: 6US FAERS
28AnxietyFAERS: 5US FAERS
29Cerebrovascular accidentFAERS: 5US FAERS
30Drug effect incompleteFAERS: 5US FAERS
31TremorFAERS: 5US FAERS
32VertigoFAERS: 5SIDER
US FAERS
33Abdominal discomfortFAERS: 4US FAERS
34Atrioventricular BlockFAERS: 4US FAERS
35Autonomic nervous system imbalanceFAERS: 4US FAERS
36ConstipationFAERS: 4SIDER
US FAERS
37DyspepsiaFAERS: 4US FAERS
38ErythemaFAERS: 4SIDER
US FAERS
39Inappropriate schedule of drug administrationFAERS: 4US FAERS
40Incorrect dose administeredFAERS: 4US FAERS
41Product use issueFAERS: 4US FAERS
42SomnolenceFAERS: 4US FAERS
43Weight decreasedFAERS: 4US FAERS
44Abdominal PainFAERS: 3US FAERS
45Activities of daily living impairedFAERS: 3US FAERS
46Atrial FlutterFAERS: 3US FAERS
47Burning sensationFAERS: 3US FAERS
48Cardiac ArrestFAERS: 3US FAERS
49Chest discomfortFAERS: 3US FAERS
50Drug administered to patient of inappropriate ageFAERS: 3US FAERS
51FlatulenceFAERS: 3US FAERS
52General physical health deteriorationFAERS: 3US FAERS
53HypersensitivityFAERS: 3US FAERS
54InfluenzaFAERS: 3US FAERS
55LethargyFAERS: 3US FAERS
56MyalgiaFAERS: 3US FAERS
57OverdoseFAERS: 3US FAERS
58PresyncopeFAERS: 3US FAERS
59Urinary tract infectionFAERS: 3US FAERS
60AlopeciaFAERS: 2US FAERS
61AmnesiaFAERS: 2US FAERS
62AngioedemaFAERS: 2SIDER
US FAERS
63ArthralgiaFAERS: 2US FAERS
64BedriddenFAERS: 2US FAERS
65Blood glucose increasedFAERS: 2US FAERS
66Blood potassium decreasedFAERS: 2US FAERS
67Blood pressure inadequately controlledFAERS: 2US FAERS
68Cardiac ablationFAERS: 2US FAERS
69ChillsFAERS: 2US FAERS
70Contraindicated product administeredFAERS: 2US FAERS
71DiplopiaFAERS: 2SIDER
US FAERS
72Drug prescribing errorFAERS: 2US FAERS
73Dry skinFAERS: 2US FAERS
74DysuriaFAERS: 2US FAERS
75FlushingFAERS: 2US FAERS
76Impaired work abilityFAERS: 2US FAERS
77LeukopeniaFAERS: 2US FAERS
78Living in residential institutionFAERS: 2US FAERS
79Loss of personal independence in daily activitiesFAERS: 2US FAERS
80Maternal exposure during pregnancyFAERS: 2US FAERS
81Memory impairmentFAERS: 2US FAERS
82NasopharyngitisFAERS: 2US FAERS
83NeuralgiaFAERS: 2US FAERS
84PainFAERS: 2US FAERS
85Peripheral swellingFAERS: 2US FAERS
86Placental InsufficiencyFAERS: 2US FAERS
87PneumoniaFAERS: 2US FAERS
88PneumothoraxFAERS: 2US FAERS
89Post procedural complicationFAERS: 2US FAERS
90Postural Orthostatic Tachycardia SyndromeFAERS: 2US FAERS
91Rebound effectFAERS: 2US FAERS
92Rehabilitation therapyFAERS: 2US FAERS
93Respiratory arrestFAERS: 2US FAERS
94StressFAERS: 2US FAERS
95Subcutaneous EmphysemaFAERS: 2US FAERS
96Supraventricular tachycardiaFAERS: 2US FAERS
97SwellingFAERS: 2US FAERS
98Transaminases increasedFAERS: 2US FAERS
99Visual brightnessFAERS: 2US FAERS
100Vitreous floatersFAERS: 2US FAERS
101Accidental exposure to product by childFAERS: 1US FAERS
102Acute kidney injuryFAERS: 1US FAERS
103Acute myocardial infarctionFAERS: 1US FAERS
104AgitationFAERS: 1US FAERS
105Alanine Aminotransferase IncreasedFAERS: 1US FAERS
106AngerFAERS: 1US FAERS
107AnuriaFAERS: 1US FAERS
108Artificial heart device userFAERS: 1US FAERS
109AstigmatismFAERS: 1US FAERS
110AuraFAERS: 1US FAERS
111Autoimmune hepatitisFAERS: 1US FAERS
112Blood creatinine abnormalFAERS: 1US FAERS
113Blood potassium increasedFAERS: 1US FAERS
114Blood pressure fluctuationFAERS: 1US FAERS
115Blood urea increasedFAERS: 1US FAERS
116Bronchial HyperreactivityFAERS: 1US FAERS
117C-reactive protein decreasedFAERS: 1US FAERS
118Cardiac FlutterFAERS: 1US FAERS
119Cardiac assistance device userFAERS: 1US FAERS
120Cardiac ventricular scarringFAERS: 1US FAERS
121Cardiovascular insufficiencyFAERS: 1US FAERS
122Catheter placementFAERS: 1US FAERS
123Cerebral hypoperfusionFAERS: 1US FAERS
124Colon adenomaFAERS: 1US FAERS
125Coronary Artery DiseaseFAERS: 1US FAERS
126DementiaFAERS: 1US FAERS
127Diabetes MellitusFAERS: 1US FAERS
128Drug DependenceFAERS: 1US FAERS
129Drug effective for unapproved indicationFAERS: 1US FAERS
130Drug screen false positiveFAERS: 1US FAERS
131DysarthriaFAERS: 1US FAERS
132DysgeusiaFAERS: 1US FAERS
133Ejection fraction abnormalFAERS: 1US FAERS
134Electrocardiogram abnormalFAERS: 1US FAERS
135EpilepsyFAERS: 1US FAERS
136EpistaxisFAERS: 1US FAERS
137Expired product administeredFAERS: 1US FAERS
138FibromyalgiaFAERS: 1US FAERS
139Gait inabilityFAERS: 1US FAERS
140GastrectomyFAERS: 1US FAERS
141Gastric ulcerFAERS: 1US FAERS
142Gastrooesophageal sphincter insufficiencyFAERS: 1US FAERS
143Genital neoplasm malignant femaleFAERS: 1US FAERS
144HepatitisFAERS: 1US FAERS
145Hypermobility syndromeFAERS: 1US FAERS
146Incorrect drug administration durationFAERS: 1US FAERS
147Incorrect product formulation administeredFAERS: 1US FAERS
148InfertilityFAERS: 1US FAERS
149InflammationFAERS: 1US FAERS
150Joint swellingFAERS: 1US FAERS
151Medication ErrorFAERS: 1US FAERS
152MenopauseFAERS: 1US FAERS
153Metabolic acidosisFAERS: 1US FAERS
154Migraine with AuraFAERS: 1US FAERS
155Musculoskeletal PainFAERS: 1US FAERS
156Myocardial InfarctionFAERS: 1US FAERS
157NervousnessFAERS: 1US FAERS
158Obsessive-Compulsive DisorderFAERS: 1US FAERS
159OnychalgiaFAERS: 1US FAERS
160OnycholysisFAERS: 1US FAERS
161Oral painFAERS: 1US FAERS
162Oxygen supplementationFAERS: 1US FAERS
163PapuleFAERS: 1US FAERS
164Peritoneal DialysisFAERS: 1US FAERS
165Personality ChangeFAERS: 1US FAERS
166Physical disabilityFAERS: 1US FAERS
167Poor quality sleepFAERS: 1US FAERS
168Product prescribing errorFAERS: 1US FAERS
169Product supply issueFAERS: 1US FAERS
170Productive CoughFAERS: 1US FAERS
171Pulmonary FibrosisFAERS: 1US FAERS
172Pulmonary congestionFAERS: 1US FAERS
173Quality of life decreasedFAERS: 1US FAERS
174RestlessnessFAERS: 1US FAERS
175RhabdomyolysisFAERS: 1US FAERS
176Sexual DysfunctionFAERS: 1US FAERS
177SinusitisFAERS: 1US FAERS
178Sleep disorder due to a general medical conditionFAERS: 1US FAERS
179Suicide attemptFAERS: 1US FAERS
180Temperature intoleranceFAERS: 1US FAERS
181Therapeutic procedureFAERS: 1US FAERS
182Therapeutic product effect delayedFAERS: 1US FAERS
183ThirstFAERS: 1US FAERS
184Thoracic vertebral fractureFAERS: 1US FAERS
185TinnitusFAERS: 1US FAERS
186Tongue discomfortFAERS: 1US FAERS
187Tracheal painFAERS: 1US FAERS
188Troponin increasedFAERS: 1US FAERS
189Urinary RetentionFAERS: 1US FAERS
190Ventricular FibrillationFAERS: 1US FAERS
191White blood cell count decreasedFAERS: 1US FAERS
192Blood and lymphatic system disordersSIDER
193Blood creatinine increasedSIDER
194Creatinine increasedSIDER
195DermatitisSIDER
196DiscomfortSIDER
197Ear and labyrinth disordersSIDER
198EosinophiliaSIDER
199MalnutritionSIDER
200ShockSIDER
201Sick Sinus SyndromeSIDER
202nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.